Phase 2 study of pembrolizumab in patients with advanced rare cancersAung Naing, Mouhammed Amir Habra, Joud Hajjar et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 130
A Durable Response With the Combination of Nivolumab and Cabozantinib in a Patient With Metastatic Paraganglioma: A Case Report and Review of the Current LiteratureMinas P. Economides, Matthew T. Campbell, Amishi Y. Shah et al.|Frontiers in Endocrinology|2020Cited by 18